← The SEC Ephemeris: the whole map
Ocular Therapeutix, Inc. DEXTENZA
In the graph: all 15 documents (325 pages).
- Application
- NDA 208742
- Ticker
- OCUL
- Product
- DEXTENZA
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- July 10, 2017 · July 21, 2016
From FDA letters and SEC filings. Not investment or medical advice.